Achilles Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	273.12	206.65	107.98	220.21	40.61
Short-Term Investments	-	-	-	901.98	-
Cash & Short-Term Investments	273.12	206.65	107.98	1,122	40.61
Cash Growth	32.17%	91.38%	-90.38%	2663.13%	-
Accounts Receivable	791.76	505.8	495.93	340.59	492.44
Other Receivables	21.88	10.65	39.93	53.12	25.96
Receivables	817.45	519.02	540.67	393.72	1,672
Inventory	599.9	482.07	492.79	409.57	453.2
Prepaid Expenses	20.4	19.96	17.15	9.29	3.08
Other Current Assets	5.74	5.35	4.41	19.34	6.74
Total Current Assets	1,717	1,233	1,163	1,954	2,176
Property, Plant & Equipment	186.09	174.19	781.94	735.23	83.95
Long-Term Investments	106.74	79.09	96.64	25.67	13.91
Other Intangible Assets	13.3	4.8	4.8	-	-
Long-Term Accounts Receivable	741.82	684.28	65.75	50.82	532.4
Long-Term Deferred Tax Assets	87.33	56.58	33.67	33.09	4.4
Total Assets	2,862	2,232	2,146	2,799	2,810
Accounts Payable	638.34	508.6	416.65	456.09	404.24
Accrued Expenses	129.77	72.65	68.04	41.55	28.59
Short-Term Debt	-	-	-	-	955.85
Current Portion of Long-Term Debt	32.78	37.3	38.11	1,203	-
Current Portion of Leases	131.33	121.5	114.64	103.73	91.74
Current Income Taxes Payable	2.78	19.88	64.42	39.58	40
Current Unearned Revenue	-	-	72.23	62.44	134.18
Other Current Liabilities	33.11	42.07	1.29	118.28	0.17
Total Current Liabilities	968.09	801.99	775.39	2,025	1,655
Long-Term Debt	300	216.74	259.07	-	-
Long-Term Leases	849.6	802.98	706.77	652.77	570.33
Long-Term Unearned Revenue	-	-	22.62	6.22	8.3
Other Long-Term Liabilities	24.98	29.05	33.37	24.65	15.78
Total Liabilities	2,145	1,852	1,799	2,710	2,250
Common Stock	553.7	549.39	549.39	549.39	0.1
Retained Earnings	222.91	-101.35	-164.8	-395.6	234.51
Comprehensive Income & Other	-54.19	-64.75	-35.7	-63.91	-2.27
Total Common Equity	722.42	383.29	348.89	89.88	232.34
Minority Interest	-5.53	-3.58	-1.68	-0.79	327.89
Shareholders' Equity	716.89	379.71	347.21	89.09	560.23
Total Liabilities & Equity	2,862	2,232	2,146	2,799	2,810
Total Debt	1,314	1,179	1,119	1,960	1,618
Net Cash (Debt)	-1,041	-971.87	-1,011	-837.63	-1,577
Net Cash Per Share	-0.67	-0.63	-0.65	-0.74	-1.51
Filing Date Shares Outstanding	1,557	1,553	1,553	1,551	1,041
Total Common Shares Outstanding	1,557	1,553	1,553	1,551	1,041
Working Capital	748.53	431.04	387.61	-70.88	520.88
Book Value Per Share	0.46	0.25	0.22	0.06	0.22
Tangible Book Value	709.12	378.49	344.09	89.88	232.34
Tangible Book Value Per Share	0.46	0.24	0.22	0.06	0.22
Machinery	88.66	68.79	57.73	52.57	84.4
Leasehold Improvements	34.32	29.69	11.91	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.